rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2011-1-5
|
pubmed:abstractText |
Molecular profiling has identified at least four subtypes of invasive breast carcinoma, which exhibit distinct clinical behaviour. There is good evidence now that DCIS represents the non-obligate precursor to invasive breast cancer and therefore it should be possible to identify similar molecular subtypes at this stage. In addition to a limited five-marker system to identify molecular subtypes in invasive breast cancer, it is evident that other biological molecules may identify distinct tumour subsets, though this has not been formally evaluated in DCIS.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Keratins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1532-1827
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
4
|
pubmed:volume |
104
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
120-7
|
pubmed:dateRevised |
2011-2-18
|
pubmed:meshHeading |
pubmed-meshheading:21139586-Adult,
pubmed-meshheading:21139586-Aged,
pubmed-meshheading:21139586-Aged, 80 and over,
pubmed-meshheading:21139586-Breast Neoplasms,
pubmed-meshheading:21139586-Carcinoma, Intraductal, Noninfiltrating,
pubmed-meshheading:21139586-Female,
pubmed-meshheading:21139586-Follow-Up Studies,
pubmed-meshheading:21139586-Humans,
pubmed-meshheading:21139586-Immunoenzyme Techniques,
pubmed-meshheading:21139586-Keratins,
pubmed-meshheading:21139586-Middle Aged,
pubmed-meshheading:21139586-Neoplasm Invasiveness,
pubmed-meshheading:21139586-Neoplasm Staging,
pubmed-meshheading:21139586-Prognosis,
pubmed-meshheading:21139586-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:21139586-Receptor, Epidermal Growth Factor,
pubmed-meshheading:21139586-Receptor, erbB-2,
pubmed-meshheading:21139586-Receptors, Estrogen,
pubmed-meshheading:21139586-Receptors, Progesterone,
pubmed-meshheading:21139586-Survival Rate,
pubmed-meshheading:21139586-Tissue Array Analysis,
pubmed-meshheading:21139586-Tumor Markers, Biological
|
pubmed:year |
2011
|
pubmed:articleTitle |
Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease.
|
pubmed:affiliation |
Centre for Tumour Biology, Institute of Cancer and CR-UK Clinical Centre, Barts and the London School of Medicine and Dentistry, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK. sarahclark74@hotmail.com
|
pubmed:publicationType |
Journal Article
|